Quality and efficacy of Multidisciplinary Team (MDT) quality assessment tools and discussion checklists: a systematic review.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Checklist* ; Interdisciplinary Communication* ; Patient Care Team*; Neoplasms/*therapy ; Quality of Health Care/*standards; Humans ; Medical Oncology/methods ; Reproducibility of Results

Background: MDT discussion is the gold standard for cancer care in the UK. With the incidence of cancer on the rise, demand for MDT discussion is increasing. The need for efficiency, whilst maintaining high standards, is therefore clear. Paper-based MDT quality assessment tools and discussion checklists may represent a practical method of monitoring and improving MDT practice. This reviews aims to describe and appraise these tools, as well as consider their value to quality improvement.
Methods: Medline, EMBASE and PsycInfo were searched using pre-defined terms. The PRISMA model was followed throughout. Studies were included if they described the development of a relevant tool, or if an element of the methodology further informed tool quality assessment. To investigate efficacy, studies using a tool as a method of quality improvement in MDT practice were also included. Study quality was appraised using the COSMIN risk of bias checklist or the Newcastle-Ottawa scale, depending on study type.
Results: The search returned 7930 results. 18 studies were included. In total 7 tools were identified. Overall, methodological quality in tool development was adequate to very good for assessed aspects of validity and reliability. Clinician feedback was positive. In one study, the introduction of a discussion checklist improved MDT ability to reach a decision from 82.2 to 92.7%. Improvement was also noted in the quality of information presented and the quality of teamwork.
Conclusions: Several tools for assessment and guidance of MDTs are available. Although limited, current evidence indicates sufficient rigour in their development and their potential for quality improvement.
Trial Registration: PROSPERO ID: CRD42021234326 .
(© 2022. The Author(s).)

Artif Intell Med. 2001 Apr;22(1):43-64. (PMID: 11259883)
Int J Gynecol Cancer. 2008 Mar-Apr;18(2):215-22. (PMID: 17511801)
Open Med. 2009;3(3):e123-30. (PMID: 21603045)
Br J Cancer. 2013 Oct 29;109(9):2295-300. (PMID: 24084764)
BJOG. 2009 Mar;116(4):511-7. (PMID: 19250362)
BMJ. 2010 Mar 23;340:c951. (PMID: 20332315)
World J Surg. 2007 Jul;31(7):1373-81. (PMID: 17487527)
J Am Coll Surg. 2013 Sep;217(3):412-20. (PMID: 23891067)
BMJ Open. 2019 May 27;9(5):e027303. (PMID: 31138582)
J Multidiscip Healthc. 2018 Jan 19;11:49-61. (PMID: 29403284)
BMJ Open. 2016 Jul 21;6(7):e012559. (PMID: 27443554)
Ann Surg Oncol. 2021 Nov;28(12):7577-7588. (PMID: 33974197)
BMJ Qual Saf. 2011 Oct;20(10):849-56. (PMID: 21610266)
Cancer. 2007 Nov 1;110(9):1937-44. (PMID: 17823912)
BMC Cancer. 2017 Nov 17;17(1):772. (PMID: 29149872)
Ann Surg Oncol. 2011 Dec;18(13):3535-43. (PMID: 21594706)
Cancer Med. 2020 Oct;9(19):7083-7099. (PMID: 32794351)
Br J Surg. 2010 Sep;97(9):1331-9. (PMID: 20641066)
PLoS One. 2019 Feb 15;14(2):e0212556. (PMID: 30768645)
Cancer Med. 2020 Jul;9(14):5143-5154. (PMID: 32476281)
Ergonomics. 2000 Aug;43(8):1129-52. (PMID: 10975177)
J Pers Soc Psychol. 1998 Jul;75(1):93-108. (PMID: 9686452)
Ann Surg Oncol. 2012 Jun;19(6):1759-65. (PMID: 22207050)
Ann Surg Oncol. 2011 Aug;18(8):2116-25. (PMID: 21442345)
BMJ Open. 2012 Jun 25;2(3):. (PMID: 22734113)
Ann Oncol. 2018 Feb 1;29(2):418-423. (PMID: 29324970)
BMC Cancer. 2012 May 29;12:202. (PMID: 22642614)
Int J Breast Cancer. 2011;2011:831605. (PMID: 22295234)
Medicine (Baltimore). 2016 Jun;95(24):e3885. (PMID: 27310981)
J Surg Oncol. 2010 Aug 1;102(2):125-34. (PMID: 20648582)
Int J Exerc Sci. 2015 Jul 1;8(3):297-302. (PMID: 27182418)
World J Surg. 2019 Feb;43(2):559-566. (PMID: 30382292)
Transl Lung Cancer Res. 2020 Jun;9(3):507-514. (PMID: 32676314)
Surg Endosc. 2014 Oct;28(10):2783-8. (PMID: 24879132)
Ann Surg Oncol. 2012 Dec;19(13):4019-27. (PMID: 22820934)
Eur J Cancer. 2006 Oct;42(15):2480-91. (PMID: 16904313)
J Urol. 2014 Sep;192(3):891-8. (PMID: 24631109)
World J Urol. 2018 Jul;36(7):1031-1038. (PMID: 29502300)
Int J Qual Health Care. 2016 Jun;28(3):332-8. (PMID: 27084499)
Acta Otolaryngol. 2007 Jan;127(1):82-7. (PMID: 17364335)
JCO Clin Cancer Inform. 2020 Aug;4:757-768. (PMID: 32816529)
Qual Life Res. 2018 May;27(5):1171-1179. (PMID: 29260445)
Cancer Treat Res Commun. 2020;25:100231. (PMID: 33157512)

Keywords: Cancer; Checklist; Discussion; Efficacy; MDT; Multidisciplinary team; Quality assessment; Tumor board

Date Created: 20220318 Date Completed: 20220325 Latest Revision: 20220325

20240628

PMC8928609

10.1186/s12885-022-09369-8

35300636